Reversibility of serum creatinine elevation observed in adpkd subjects receiving the tyrosine kinase inhibitor tesevatinib

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2017
This article has no abstract
Epistemonikos ID: 8ebe8b6665e061738405ff28ccf46da8ddef8261
First added on: Feb 12, 2025